Serial Number
97437045
Owner
Liling biopharmaceuticals (Suzhou) Co., LtdFirst Use Date
May 5, 2022
Filing Date
May 31, 2022
TUREAC-T Trademark
Serial Number: 97437045 • Registration: 7100501
Trademark Classes
Owner Contact Info
Room 502, Building 1, Shunda Commercial
Jiangsu 215000 , CN
Entity Type: 99
Legal Representation
Correspondence Address
Liling biopharmaceuticals (Suzhou) Co., Ltd
Room 502, Building 1, Shunda Commercial
Plaza, Suzhou Industrial Park,
Jiangsu, 215000
CHINA
Trademark Details
Filing Date
May 31, 2022
Registration Date
July 4, 2023
First Use Anywhere
May 5, 2022
First Use in Commerce
May 5, 2022
Published for Opposition
April 18, 2023
Goods & Services
Immunostimulants; Biological preparations for the treatment of cancer; Disinfecting wipes; First aid kits; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents